Connor, Clark & Lunn Investment Management Ltd. Meridian Bioscience Inc Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$13.54 - $26.41 $210,831 - $411,230	-15,571 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$7.84 - $23.29 $684,659 - $2.03 Million	-87,329 Reduced 84.87%	15,571 $363,000
Q1 2020 May 13, 2020	BUY	$5.57 - $11.5 $201,634 - $416,300	36,200 Added 54.27%	102,900 $864,000
Q4 2019 Feb 12, 2020	SELL	$7.9 - $10.14 $304,742 - $391,150	-38,575 Reduced 36.64%	66,700 $652,000
Q3 2019 Nov 13, 2019	BUY	$9.17 - $12.01 $208,617 - $273,227	22,750 Added 27.57%	105,275 $999,000
Q2 2019 Aug 07, 2019	BUY	$10.88 - $17.6 $897,872 - $1.45 Million	82,525 New	82,525 $980,000
Q1 2019 May 08, 2019	SELL	$15.51 - $17.61 $354,403 - $402,388	-22,850 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$14.52 - $19.72 $1.06 Million - $1.44 Million	-72,900 Reduced 76.14%	22,850 $397,000
Q3 2018 Nov 13, 2018	BUY	$14.85 - $16.35 $407,261 - $448,398	27,425 Added 40.14%	95,750 $1.43 Million
Q2 2018 Aug 02, 2018	BUY	$13.8 - $16.8 $323,265 - $393,540	23,425 Added 52.17%	68,325 $1.09 Million
Q1 2018 May 14, 2018	BUY	$13.8 - $16.2 $252,540 - $296,460	18,300 Added 68.8%	44,900 $638,000
Q4 2017 Feb 09, 2018	BUY	$13.55 - $15.8 $138,548 - $161,555	10,225 Added 62.44%	26,600 $372,000
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $220,243 - $234,981	16,375	16,375 $234,000

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account